Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
South Korea Unveils Record $597 Billion 2027 Budget to Boost AI and Chips 
OpenAI Rejects Apple Trade Secret Theft Claims 
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
France Targets Shein, Temu With Fast-Fashion Fees 
Trump Secures Drug Pricing Deals With Nine Pharma Companies 
CIA-Linked Investor Helped Quantum Systems Expand in US 
Shein Shares Slide 9% in Hong Kong IPO Debut 
Add as a preferred source on Google
TUSTIN, Calif., March 13, 2018 -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate at two upcoming CDMO industry conferences. These include KNect365 Life Sciences’ BioProcess International West 2018, being held March 19-22, 2018 in San Francisco, CA, and DCAT Week 2018, being held March 19-22, 2018 in New York, NY.
Details of these activities are as follows:
KNect365 Life Sciences' BioProcess International West:
Avid will host corporate booth #415 showcasing the company’s comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services. Company representatives will provide a virtual tour of Avid’s 40,000 square foot state-of-the-art commercial biomanufacturing suite (Myford facility). The Myford facility is designed with cutting-edge, single-use equipment to accommodate a fully disposable biomanufacturing process. A wide range of innovative features are incorporated into the facility including monolithic modular clean rooms, dedicated support utilities for each key processing area, and the industry’s most advanced single-use production systems and flexible solutions. Uni-directional process flows separate personnel and materials and provide assurance that the design meets the most stringent regulatory requirements for commercial biologics API manufacturing.
DCAT Week:
Avid representatives will also be onsite at DCAT Week, an event hosted by the Drug, Chemical & Associated Technologies Association (DCAT). In addition to participating in related networking events, the company is hosting a table at the DCAT Annual Dinner on Thursday, March 22.
For additional details on these events, please visit: https://lifesciences.knect365.com/bpi-west/ and https://dcatweek.org/.
About Avid Bioservices, Inc.
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With nearly 25 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. www.avidbio.com
Contacts: Kelly Pisarev Lord Avid Bioservices, Inc. (800) 987-8256 Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 [email protected] Tim Brons (Media) Vida Strategic Partners 415-675-7402 [email protected]
